Results 41 to 50 of about 76,712 (310)
Diagnostic delay in axial spondyloarthritis: a systematic review
Clinical Rheumatology, 2022 Identification of axial spondyloarthritis (axSpA) remains challenging, frequently resulting in a diagnostic delay for patients. Current benchmarks of delay are usually reported as mean data, which are typically skewed and therefore may be overestimating ...
Charles A. Hay +5 more
semanticscholar +1 more source
Psychiatric aspects of spondyloarthritis
Научно-практическая ревматология, 2021 Spondyloarthritis refers to immune-mediated inflammatory rheumatic diseases characterized by the most pronounced pain, inflammatory activity and disability of patients of working age.
T. A. Lisitsyna +3 more
doaj +1 more source
Co-Occurrence and Characteristics of Patients With Axial Spondyloarthritis Who Meet Criteria for Fibromyalgia : Results From a UK National Register [PDF]
, 2017 The British Society for Rheumatology (BSR) Biologics Register in Ankylosing Spondylitis is funded by the BSR and they have receive funds for this from Pfizer, AbbVie and UCB.
Atzeni, Fabiola +8 more
core +2 more sources
PLoS ONE, 2020 Spondyloarthritis Research Consortium Canada (SPARCC) score is an effective magnetic resonance imaging (MRI) evaluation method for inflammation in axial spondyloarthritis.
Yupeng Huang +5 more
doaj +1 more source
99mTc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients : a biodistribution and dosimetry study [PDF]
, 2016 Background: Biologicals directed against tumour necrosis factor (TNF) have proven their efficacy in the treatment of spondyloarthritis and rheumatoid arthritis.
Bacher, Klaus +9 more
core +2 more sources
Case Reports in Rheumatology, 2023 Objective. To describe four peripheral spondyloarthritis patients presenting with fever and severe systemic inflammatory response mimicking infection. Methods.
Ibrahim Abdulmomen +2 more
doaj +1 more source
Tumor necrosis factor inhibitors in psoriatic arthritis. [PDF]
, 2017 INTRODUCTION: Psoriatic arthritis (PsA) is a chronic inflammatory disease that can result in significant disability. With the emergence of tumor necrosis factor inhibitors (TNFi), therapeutic outcomes in PsA have improved substantially.
Kraft, Walter K. +2 more
core +2 more sources
Symptom modifiers in therapy for ankylosing spondylitis
Неврология, нейропсихиатрия, психосоматика, 2010 Based on the data available in the literature, the author gives information on the prevalence of ankylosing spondyloarthritis. The clinical picture and pathogenesis of this disease and the principles of its diagnosis and treatment are described ...
V. V. Badokin
doaj +1 more source
Scotland Registry for Ankylosing Spondylitis (SIRAS) – Protocol [PDF]
, 2016 Funding SIRAS was funded by unrestricted grants from Pfizer and AbbVie. The project was reviewed by both companies, during the award process, for Scientific merit, to ensure that the design did not compromise patient safety, and to assess the global ...
Dean, Linda E +10 more
core +1 more source
Bone marrow edema in sacroiliitis : detection with dual-energy CT
, 2020 Objectives: To evaluate the feasibility and diagnostic accuracy of dual-energy computed tomography (DECT) for the detection of bone marrow edema (BME) in patients suspected for sacroiliitis. Methods: Patients aged 18-55 years with clinical suspicion for
Carron, Philippe +6 more
core +1 more source